Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for early-stage investigators who are NIH-eligible and conducting research funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Applicants must be within 10 years of completing their final degree or clinical residency/fellowship and hold at least a 50% appointment at an eligible institution. The R01 mechanism supports research projects across a broad range of topics, though clinical trials are not permitted under this specific R01 variant. Eligible recipients include research institutions such as universities, medical schools, hospitals, and other nonprofit or for-profit organizations that meet NIH requirements. The grant can support domestic and international research conducted by investigators at U.S. institutions.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- NIH Standard Form SF-424 (R&R) and SF-424 (R&R) Subaward Budget Attachment Form
- Project narrative (typically 15 pages, with specific formatting requirements per NIH guidelines)
- Detailed budget and budget justification (modular or categorical)
- NIH biosketch (5 pages, specific format required)
- Biosketches for all key personnel
- Letters of support from mentor(s) and institutional leadership
- Institutional support letter demonstrating 50%+ appointment
- Protection of human subjects documentation (if applicable)
- Data management and sharing plan
- Facilities and resources documentation
- Letters of collaboration (if applicable)
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.213 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$22,367,527
-
$21,646,919
-
$19,236,131
-
$17,730,528
-
$15,036,701
-
$14,473,882
-
$12,748,932
-
$11,956,053
-
$11,225,697
-
$10,919,780
Top States by Funding
- CA 13 awards $83.5M
- MA 13 awards $80.2M
- WA 8 awards $69.9M
- NC 7 awards $53.8M
- NY 6 awards $40.0M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.213). How funding has trended year over year.
| 2024 | $240,178,154 | |
| 2025 | $232,899,116 | |
| 2026 est. | $2,655,626 |
FAQ
What is considered "early-stage investigator" status for this grant?
Generally, an early-stage investigator is within 10 years of completing their final degree (MD, PhD, DDS, or equivalent) or clinical residency/fellowship, and has not served as a principal investigator on a substantial NIH research grant. Specific eligibility rules apply; consult NIH's STEP database or your institution's research office.
Can I include clinical trials in my research proposal?
No. This specific R01 variant explicitly does not allow clinical trials. If your research involves human subjects in a clinical trial context, you will need to apply for a different NIH mechanism such as the standard R01 or R61/R33.
What is the typical award amount and project period?
R01 grants typically support 3-5 years of research with budgets ranging from $200,000 to $500,000+ per year depending on the field and complexity, though actual amounts vary. Review the latest NIH funding announcements and program guidelines for current ranges.
When are applications due?
The application deadline is August 25, 2028. Application submission opens August 25, 2025. Check NIH's Grants.gov website for any updated deadlines or rolling submission dates.
How competitive is this funding opportunity?
R01 grants are highly competitive, with success rates typically in the 20-25% range across NIH. Early-stage investigator programs often have slightly better funding rates. Strong preliminary data, clear innovation, and institutional support are critical to competitiveness.
💡 Tips for applicants
- Build a strong track record of preliminary data. Reviewers want evidence that you can execute the proposed research. Pilot studies, published work, or preliminary findings significantly strengthen your application.
- Clearly articulate the innovation and significance of your research. Explain how your work addresses important gaps in the field and why it matters for human health or basic science understanding.
- Obtain strong letters of support from your mentor and institutional leadership. Early-stage investigators benefit greatly from demonstrated mentorship and institutional commitment to your independence.
- Use the NIH biosketch and other biographical documents strategically to highlight your progress toward scientific independence. For early-stage investigators, showing a clear trajectory is important.
- Allow sufficient time for internal institutional review and approval. Many research institutions require 2-4 weeks of internal review before submission to NIH; plan accordingly given the August 2028 deadline.
⚠️ Common mistakes
Applications often fail due to lack of preliminary data or insufficient evidence of the applicant's capacity to conduct the proposed research independently. Many early-stage investigators underestimate the importance of clearly demonstrating how they are transitioning toward research independence from mentors. Additionally, applications that lack a clear, realistic timeline, overreach in scope, or fail to clearly state specific aims and measurable milestones are frequently not competitive.
Similar grants
- OPEN Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) — National Institutes of Health
- OPEN NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN NIH Research Project Grant (Parent R01 Clinical Trial Required) — National Institutes of Health